Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BTD timeline...

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Apr 25, 2022 12:34pm

262 Views

Post# 34629319

RE:RE:RE:RE:RE:RE:RE:BTD timeline...

TLT could, on its side, delay this, if it wanted to put all the chances on its side and add 12 more patients to the negative impact of the first 12 undosed, so they could present data on the first 37 patients. That's an option they could give to themselves to ensure that the % of efficacy are to its advantage.

But Eoganacht showed that even with the first 25, our chances are good as the % of efficacy still above competition.

It's an tough and important call as you only have one chance to make a good impression, so don't spoil it.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec